%PDF-1.4
%
180 0 obj
<>
endobj
177 0 obj
<>
endobj
232 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-04-07T16:52:49Z
2024-03-28T03:32:56-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T03:32:56-07:00
application/pdf
Heather
2004-333.may
uuid:e17ed944-1dd1-11b2-0a00-3609275d6100
uuid:e17ed946-1dd1-11b2-0a00-aa0000000000
endstream
endobj
164 0 obj
<>
endobj
166 0 obj
<>
endobj
165 0 obj
<>
endobj
167 0 obj
<>
endobj
132 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 158 0 R/Type/Page>>
endobj
233 0 obj
[238 0 R]
endobj
234 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 1 K
/GS1 gs
53.964 76.5 m
558.972 76.5 l
S
0 0 0 0 k
52.822 69.665 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_0 1 Tf
8 0 0 8 53.8216 56.7343 Tm
(886)Tj
ET
0 0 0 0 k
356 69.665 203 -15.665 re
f*
BT
0 0 0 1 k
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 424.3613 56.7343 Tm
(The Journal of Rheumatology 2005; 32:5)Tj
ET
0 0 0 0 k
/GS0 gs
102.631 81.25 407.5 -10.833 re
f*
0.5 w
/GS1 gs
102.631 81.25 407.5 -10.833 re
S
BT
0 0 0 1 k
/T1_1 1 Tf
8 0 0 8 73.868 737.0293 Tm
(human hips. II. Correlation of biochemical and metabolic data. )Tj
0 -1.25 TD
[(J Bone Joint Sur)17.7 (g )54.8 (Am 1971;53:523-37.)]TJ
-2.175 -1.25 Td
[(21.)-875.1 (Hollander )54.8 (AP)110.7 (, Pidoux I, Reiner )54.8 (A, Rorabeck C, Bourne R, Poole)]TJ
2.175 -1.25 Td
[(AP)110.8 (. Damage to type II collagen in aging and osteoarthritis starts at)]TJ
T*
(the articular surface, originates around chondrocytes and extends)Tj
T*
(into the cartilage with progressive degeneration. J Clin Invest)Tj
0 Tc 0 Tw T*
(1995;96:2859-69.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(22.)-875.1 (Chomczynski P)110.7 (, Sacchi N. Single-step method of RNA)-220.2 (isolation by)]TJ
2.175 -1.25 Td
[(acid guanidium thiocyanate-phenol-chloroform extraction. )54.8 (Anal)]TJ
T*
(Biochem 1987;162:156-9.)Tj
-2.175 -1.25 Td
[(23.)-875.1 (Aigner )17.7 (T)74 (, Kim HA. )54.8 (Apoptosis and cellular vitality: issues in)]TJ
2.175 -1.25 Td
[(osteoarthritic cartilage degeneration. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2002;46:1986-96.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(24.)-875.1 (Dean DD, )54.8 (Azzo )17.7 (W)91.8 (, Martel-Pelletier J, Pelletier JP)110.7 (, Howell DS,)]TJ
2.175 -1.25 Td
[(W)79.9 (oessner JF)79.7 (. Evidence for metalloproteinase and metalloproteinase)]TJ
T*
(inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest)Tj
0 Tc 0 Tw T*
(1989;84:678-85.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(25.)-875.1 (Iwamoto M, Shimazu )54.8 (A, Pacifici M. Regulation of chondrocyte)]TJ
2.175 -1.25 Td
[(maturation by fibroblast growth factor)19.7 (-2 and parathyroid hormone.)]TJ
T*
(J Orthop Res 1995;13:838-45.)Tj
-2.175 -1.25 Td
[(26.)-875.1 (St-Jacques B, Hammerschmidt M, McMahon )54.8 (AP)110.8 (. Indian hedgehog)]TJ
2.175 -1.25 Td
[(signaling regulates proliferation and dif)17.7 (ferentiation of chondrocytes)]TJ
T*
(and is essential for bone formation. Genes Dev 1999;13:2072-86.)Tj
-2.175 -1.25 Td
[(27.)-875.1 (Serra R, Karaplis )54.8 (A, Sohn P)110.7 (. Parathyroid hormone-related peptide)]TJ
2.175 -1.25 Td
[(\(PTHrP\)-dependent and independent ef)17.7 (fects of transforming growth)]TJ
T*
(factor beta \(TGF beta\) on endochondral bone formation. J Cell Biol)Tj
0 Tc 0 Tw T*
(1999;145:783-94.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(28.)-875.1 (De Crombrugghe B, Lefebvre )17.7 (V)128.9 (, Behringer RR, Bi )17.7 (W)91.9 (, Murakami S,)]TJ
2.175 -1.25 Td
[(Huang )17.7 (W)91.9 (.)-0.1 ( )17.7 (T)35 (ranscriptional mechanisms of chondrocyte)]TJ
T*
[(dif)17.7 (ferentiation. Matrix Biol 2000;19:389-94.)]TJ
-2.175 -1.25 Td
[(29.)-875.1 (Jimenez MJG, Balbin M, Lopez JM, )54.8 (Alvarez J, Komori )17.7 (T)74 (, Lopez-)]TJ
2.175 -1.25 Td
[(Otin C. Collagenase 3 is a tar)17.7 (get of Cbfa1, a transcription factor of)]TJ
T*
(runt gene family involved in bone formation. Mol Cell Biol)Tj
0 Tc 0 Tw T*
(1999;19:4431-42.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(30.)-875.1 (Caterson B, Flannery CR, Hughes CE, Little CB. Mechanisms)]TJ
2.175 -1.25 Td
(involved in cartilage proteoglycan catabolism. Matrix Biol)Tj
0 Tc 0 Tw T*
(2000;19:333-44.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(31.)-875.1 (Bau B, Gebhard PM, Haag J, Knorr )17.7 (T)74 (, Bartnik E, )54.8 (Aigner )17.7 (T)74 (.)]TJ
2.175 -1.25 Td
[(Relative messenger RNA)-220.2 (expression profiling of collagenases and)]TJ
T*
(aggrecanases in human articular chondrocytes in vivo and in vitro.)Tj
T*
(Arthritis Rheum 2002;46:2648-57.)Tj
-2.175 -1.25 Td
[(32.)-875.1 (Fan Z, Chubinskaya S, Rueger DC, Bau B, Haag J, )54.9 (Aigner )17.8 (T)74 (.)]TJ
2.175 -1.25 Td
(Regulation of anabolic and catabolic gene expression in normal and)Tj
T*
(osteoarthritic adult human articular chondrocytes by osteogenic)Tj
T*
(protein-1. Clin Exp Rheumatol 2004;22:103-6.)Tj
0 Tc -2.175 -1.25 Td
[(33.)-875 (Shlopov BV)128.9 (, Lie )17.7 (W)55.1 (-R, Mainardi CL, Cole )54.8 (AA, Chubinskaya S,)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(Hasty KA. Osteoarthritic lesions \321 Involvement of three dif)17.7 (ferent)]TJ
T*
[(collagenases. )54.8 (Arthritis Rheum 1997;40:2065-74.)]TJ
-2.175 -1.25 Td
[(34.)-875.1 (Freemont )54.8 (AJ, Hampson )17.7 (V)128.9 (,)-0.1 ( )17.7 (T)35 (ilman R, Goupille P)110.7 (,)-0.1 ( )17.7 (T)69.9 (aiwo )36.8 (Y)128.9 (,)-0.1 ( Hoyland)]TJ
2.175 -1.25 Td
(JA. Gene expression of matrix metalloproteinases 1, 3, and 9 by)Tj
T*
(chondrocytes in osteoarthritic human knee articular cartilage is)Tj
T*
[(zone and grade specific. )54.8 (Ann Rheum Dis 1997;56:542-9.)]TJ
-2.175 -1.25 Td
[(35.)-875.1 (Mankin HJ. Localization of tritiated cytidine in articular cartilage of)]TJ
2.175 -1.25 Td
(immature and adult rabbits after intraarticular injection. Lab Invest)Tj
0 Tc 0 Tw T*
(1964;2:543-8.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(36.)-875.1 (Sandell LJ, )54.8 (Aigner )17.7 (T)74 (.)-0.1 ( )54.8 (Articular cartilage and changes in arthritis. )54.8 (An)]TJ
2.175 -1.25 Td
[(introduction: Cell biology of osteoarthritis. )54.8 (Arthritis Res)]TJ
0 Tc 0 Tw T*
(2001;3:107-13.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(37.)-875.1 (Kusuzaki K, Sugimoto S, )17.7 (T)69.9 (akeshita H, et al. DNA)-220.2 (cytometric)]TJ
2.175 -1.25 Td
(analysis of chondrocytes in human articular cartilages under normal)Tj
-0.0051 Tc T*
(aging or arthritic conditions. Osteoarthritis Cartilage 2001;9:664-70.)Tj
-0.00011 Tc 30.825 75 Td
[(38.)-875.1 (Aigner )17.7 (T)74 (, Hemmel M, Neureiter D, et al. )54.8 (Apoptotic cell death is not)]TJ
2.175 -1.25 Td
(a widespread phenomenon in normal aging and osteoarthritic)Tj
T*
(human articular knee cartilage: a study of proliferation,)Tj
T*
(programmed cell death \(apoptosis\), and viability of chondrocytes in)Tj
T*
[(normal and osteoarthritic human knee cartilage. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2001;44:1304-12.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(39.)-875.1 (Aigner )17.7 (T)74 (, Kurz B, Fukui N, Sandell L. Roles of chondrocytes in the)]TJ
-0.0101 Tc 2.175 -1.25 Td
(pathogenesis of osteoarthritis. Curr Opin Rheumatol 2002;14:578-84.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(40.)-875.1 (Aigner )17.7 (T)74 (, McKenna L. Molecular pathology and pathobiology of)]TJ
2.175 -1.25 Td
(osteoarthritic cartilage. Cell Mol Life Sci 2002;59:5-18.)Tj
-2.175 -1.25 Td
[(41.)-875.1 (Martin JA, Buckwalter JA. )54.8 (Aging, articular cartilage chondrocyte)]TJ
2.175 -1.25 Td
(senescence and osteoarthritis. Biogerontology 2002;3:257-64.)Tj
-2.175 -1.25 Td
[(42.)-875.1 (W)79.9 (asner M, Haugwitz U, Reinhard )17.7 (W)91.8 (, et al. )17.7 (Three CCAA)110.7 (T)91.8 (-boxes)]TJ
2.175 -1.25 Td
(and a single cell cycle genes homology region \(CHR\) are the major)Tj
T*
(regulating sites for transcription from the human cyclin B2)Tj
0 Tc T*
[(promoter)54.9 (. Gene 2003;312:225-37.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(43.)-875.1 (Poole )54.8 (AR. )17.7 (What type of cartilage repair are we attempting to attain?)]TJ
0 Tc 2.175 -1.25 Td
[(J Bone Joint Sur)17.8 (g )54.8 (Am 2003;85 Suppl 2:40-4.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(44.)-875.1 (Aigner )17.7 (T)74 (, Gluckert K, von der Mark K. )54.8 (Activation of fibrillar)]TJ
2.175 -1.25 Td
(collagen synthesis and phenotypic modulation of chondrocytes in)Tj
T*
(early human osteoarthritic cartilage lesions. Osteoarthritis Cartilage)Tj
0 Tc 0 Tw T*
(1997;5:183-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(45.)-875.1 (Aigner )17.7 (T)74 (,)-0.1 ( Stoss H, )17.7 (W)79.9 (eseloh G, Zeiler G, von der Mark K.)]TJ
2.175 -1.25 Td
(Activation of collagen type II expression in osteoarthritic and)Tj
T*
[(rheumatoid cartilage. )17.7 (V)59.8 (irchows )54.8 (Arch 1992;B62:337-45.)]TJ
-2.175 -1.25 Td
[(46.)-875.1 (Aigner )17.7 (T)74 (,)-0.1 ( )17.7 (V)128.9 (ornehm SI, Zeiler G, Dudhia J, von der Mark K, Bayliss)]TJ
2.175 -1.25 Td
[(MT)73.9 (. Suppression of cartilage matrix gene expression in upper zone)]TJ
T*
[(chondrocytes of osteoarthritic cartilage. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1997;40:562-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(47.)-875.1 (Hardingham )17.7 (TE, Fosang )54.8 (AJ, Dudhia J. )54.8 (Aggrecan, the chondroitin)]TJ
2.175 -1.25 Td
(sulfate/keratan sulfate proteoglycan from cartilage. In: Kuettner)Tj
T*
[(KE, Schleyerbach R, Peyron JG, Hascall )17.7 (VC, editors. )54.8 (Articular)]TJ
T*
[(cartilage and osteoarthritis. New )36.8 (Y)99.8 (ork: Raven Press; 1992.)]TJ
-2.175 -1.25 Td
[(48.)-875.1 (van Kampen GPJ, van de Stadt RJ, van de Laar )54.8 (AFJ, van der Korst)]TJ
2.175 -1.25 Td
[(JK. )17.7 (T)69.9 (wo distinct metabolic pools of proteoglycans in articular)]TJ
T*
(cartilage. In: Kuettner KE, Schleyerbach R, Peyron JG, Hascall)Tj
T*
[(VC, editors. )54.8 (Articular cartilage and osteoarthritis. New )36.8 (Y)99.8 (ork: Raven)]TJ
T*
(Press; 1992. )Tj
-2.175 -1.25 Td
[(49.)-875.1 (van den Ber)17.7 (g )17.7 (WB. Growth factors in experimental osteoarthritis:)]TJ
2.175 -1.25 Td
[(T)35 (ransforming growth factor beta pathogenic? J Rheumatol 1995;22)]TJ
0 Tc T*
(Suppl 43:143-5.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(50.)-875.1 (Scharstuhl )54.8 (A, Glansbeek HL, van Beuningen HM, )17.7 (V)59.8 (itters EL, van)]TJ
2.175 -1.25 Td
[(der Kraan PM, van den Ber)17.7 (g )17.7 (WB. Inhibition of endogenous )17.7 (TGF-)]TJ
T*
(beta during experimental osteoarthritis prevents osteophyte)Tj
-0.005 Tc T*
[(formation and impairs cartilage repair)54.8 (. J Immunol 2002;169:507-14.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(51.)-875.1 (Bos PK, van Osch JVM, Frenz DA, )17.7 (V)110.8 (erhaar JAN, )17.7 (V)110.8 (erwoerd-)]TJ
2.175 -1.25 Td
[(V)110.8 (erhoef HL. Growth factor expression in cartilage wound healing:)]TJ
T*
(temporal and spatial immunolocalization in a rabbit auricular)Tj
T*
(cartilage wound model. Osteoarthritis Cartilage 2001;9:382-9.)Tj
-2.175 -1.25 Td
[(52.)-875.1 (Goggs R, Carter SD, Schulze-T)69.7 (anzil G, Shakibaei M, Mobasheri )54.8 (A.)]TJ
2.175 -1.25 Td
(Apoptosis and the loss of chondrocyte survival signals contribute to)Tj
T*
[(articular cartilage degradation in osteoarthritis. )17.7 (V)110.8 (et J 2003;)]TJ
0 Tc 0 Tw T*
(166:140-58.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(53.)-875.1 (Lotz M, Hashimoto S, Kuhn K. Mechanisms of chondrocyte)]TJ
2.175 -1.25 Td
(apoptosis. Osteoarthritis Cartilage 1999;7:389-91.)Tj
-2.175 -1.25 Td
[(54.)-875.1 (Kuhn K, D\325Lima DD, Hashimoto S, Lotz M. Cell death in)]TJ
2.175 -1.25 Td
(cartilage. Osteoarthritis Cartilage 2004;12:1-16.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
158 0 obj
<>stream
8;Z\6$$,#j%+P;A38[;Yh1oO#0b,O#TupsRa?$q;N:F0&AT@U(\Ga&>GPc0$]mP3W
/+c022ocPhcRq+I(\S*_ejtaN]ZYBe^&KrhhGX,AB!Q%][;%PbaY=&qZ`=PkXmN2#
N9&0MdUb>iYj$0f$FR4)VT1i$`rq^QDQhe[";0S%aA":IJ1$6@RL/o=+7&J=[E-uo
e3Xc=Ze>ioL@)-6lUoDK#G
C+f44$EP!m5E6!c?&P_!7EP2F2R3Y8O$muM3R7a'<;K5s<-1i.QcS8faI
ViWOOB1#6Fd9NTm!V!&Kmf:B@I*_/lTI?iSKa7?.\gcB[q@uEq=Q^NC9nuPF.?PG&
e'[o\dheQ6m`.DN0+HEjXF0(:.FLWS$W)bJSIr`A'c0I^9;56.,\TJ17baXt'S=dW
[Dh`WWFuqm-ICecgnZtn>j"Z\n8*,E3YK=+
,J%KM;ndBR:X3_\nZ;(G"(6K([j5O_#o>gXU6#7VM\A".E]X/!FZi;0
.D\)@g;j2sI160JPdk$~>
endstream
endobj
162 0 obj
[/Indexed/DeviceRGB 255 161 0 R]
endobj
161 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
187 0 obj
<>
endobj
191 0 obj
<>
endobj
209 0 obj
<>
endobj
237 0 obj
<>
endobj
192 0 obj
<>
endobj
201 0 obj
<>stream
H|TPSWp0Fn[UC ((%B CD0JCDEATJT,_VwFݙ8;g3|YZ`8kCWW+axyRVqłe8%+q@>(_vN
1gڥRRG+Udrdnԇw/%ԏV7K*Ev)$듵:EVҨUNP"ILJZFo]UJFkJT1`eJVHd$h7F4viJFic`<fc1&41%0̀ayVan
_XẔH Nv|m\;;4ώW{͗Zaaۺi))Oml>%lSmA 4E۽ϴiꂩSS"H!
Ls%dzj5"D#G2ŷ3[j;j(j.]hLw5~hla@!&qt+BVb)Q=qhN|8?/*/d&'<
xSt<)!_1+\ɜ_-ZT/i(y>2xyO9?n0|i`b0g8
jJ/0փ~@+TAB~P@H|fPdgCFlaN+RpO ~8a\U˙xf)Z,)ћx&|Ɂ6\ 6WVk5ϡ9
M
P*1q'cht-]͏gs'D`}mobB,5c7poT1@WxL)8Ӝ-ih]>EvQ.[}N
0_<}*}AGDz!(QW>2&lw4LRaydIlPН\d(xe=#%R(0AEoaŁˁ e?/YBfdf$pt-<C
-@~5A}s(ʘp`Q W,>[2Z}/Hc-; (4E?r0/r
Q`
Ͱ>ˇf
g :>څZW
s>@`AQZSZ*9YHPg'߱24rSvF~PEt7A<m 40oc {Au'|=Gπ/Ƀmfȉֳe~/g̏5ek~.&?h#b
)@Uvym_>FavzCEֲo((9
!=d:诮kԄ?}N3\? ^+xFbvنC80~~j,ҷ }7a+Ǜpo,K? )gl
iH??@JϳM ~6Þa 6hwYg; []52NL\